Vin Singh, Founder & CEO of BullFrog AI BFRGW, recently engaged in a discussion with Benzinga.
By offering its bfLEAP platform, BullFrog AI, a technology firm, is fundamentally altering the landscape of precision medicine. The platform harnesses the power of predictive analytics across all facets of drug development, potentially heralding a paradigm shift in this arena.
Notably, the company has collaborated with Johns Hopkins University, a globally esteemed research institution, to secure a license for its AI technology.
Explore further details at:
Featured photo by Louis Reed on Unsplash.
This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.